SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: chirodoc who wrote (624)12/20/1997 2:11:00 PM
From: scott harrison  Read Replies (2) | Respond to of 887
 
<<the stock will be dead money for a year>> Chirodoc: You don't know this. The stock could either head down to Bico's price (.25) or head up. The company and stock will be watched much more closely in the short term. It dropped 70 percent, and those looking for bargains in the stock market might consider if DEPO convinces them they've got a chance "working with the FDA" for Depocyte, and also if the company anounces positive results for other drugs in the pipeline. I guarantee you the stock price will look very very differently in a year. I can't begin to guess where it'll be, but dead money is a bad expression. Holding 700 shares bought at 15. scott



To: chirodoc who wrote (624)12/20/1997 3:30:00 PM
From: John McCarthy  Read Replies (3) | Respond to of 887
 
Doc -

We agree.

Dead money till signs of another meeting.

Regards,

John